What's more, as mentioned above, upregulation of PDK2 is associated with metabolic reprogramming and chemoresistance of cancer cells, so it is also worth studying whether DUXAP8 can modulate these phenotypes of HCC cells. Here, DUXAP8 is linked to hepatocellular carcinoma.